Literature DB >> 9517481

Activation of gp130 by IL-6/soluble IL-6 receptor induces neuronal differentiation.

P März1, T Herget, E Lang, U Otten, S Rose-John.   

Abstract

Interleukin-6 (IL-6) on target cells binds to the specific IL-6 receptor (IL-6R) and subsequently induces homodimerization of the signal-transducing protein gp130. Cells which express gp130 but no IL-6R and which therefore do not respond to IL-6 can be stimulated by the complex of IL-6 and soluble IL-6R (slL-6R). Here we show that on rat pheochromocytoma cells (PC12), the combination of IL-6 and slL-6R but not IL-6 alone induces expression of c-fos, GAP-43 and neuron-specific enolase followed by neuron-specific differentiation and formation of a neuronal network. The differentiation was dose-and time-dependent and followed the same kinetics as nerve-growth factor (NGF)-induced differentiation. The responses of PC12 cells to IL-6/sIL-6R and NGF were additive, suggesting independent signaling pathways. We demonstrate that activation of gp130 generates a neuronal differentiation signal that is equivalent to and independent of trk/NGF receptor tyrosine kinase. Interestingly, the failure of IL-6 to induce differentiation of PC12 cells is not due to lack of surface expression of IL-6R as IL-6 alone triggered expression of GAP-43 mRNA and protein. We hypothesize that PC12 cells express more gp130 than IL-6R and that the extent of activated gp130 molecules determines the quality of the response.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9517481     DOI: 10.1111/j.1460-9568.1997.tb01705.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  23 in total

Review 1.  Neurotrophic factors and their receptors in axonal regeneration and functional recovery after peripheral nerve injury.

Authors:  J Gordon Boyd; Tessa Gordon
Journal:  Mol Neurobiol       Date:  2003-06       Impact factor: 5.590

Review 2.  Immunoinflammatory diseases of the central nervous system - the tale of two cytokines.

Authors:  M J Hofer; I L Campbell
Journal:  Br J Pharmacol       Date:  2015-06-12       Impact factor: 8.739

3.  Cyclosporine A-Mediated IL-6 Expression Promotes Neural Induction in Pluripotent Stem Cells.

Authors:  Ashwathnarayan Ashwini; Sushma S Naganur; Bhaskar Smitha; Preethi Sheshadri; Jyothi Prasanna; Anujith Kumar
Journal:  Mol Neurobiol       Date:  2017-06-16       Impact factor: 5.590

4.  Interleukin-6-Mediated Induced Pluripotent Stem Cell (iPSC)-Derived Neural Differentiation.

Authors:  Yanuar Alan Sulistio; Han Kyu Lee; Sung Jun Jung; Klaus Heese
Journal:  Mol Neurobiol       Date:  2017-05-16       Impact factor: 5.590

5.  Expression of pancreatitis-associated protein after traumatic brain injury: a mechanism potentially contributing to neuroprotection in human brain.

Authors:  Pia März-Weiss; Dieter Kunz; Daniel Bimmler; Caroline Berkemeier; Suat Özbek; Beatrice Dimitriades-Schmutz; Johannes Haybaeck; Uwe Otten; Rolf Graf
Journal:  Cell Mol Neurobiol       Date:  2011-06-05       Impact factor: 5.046

6.  The ciliary neurotrophic factor/leukemia inhibitory factor/gp130 receptor complex operates in the maintenance of mammalian forebrain neural stem cells.

Authors:  T Shimazaki; T Shingo; S Weiss
Journal:  J Neurosci       Date:  2001-10-01       Impact factor: 6.167

7.  Trans-signaling is a dominant mechanism for the pathogenic actions of interleukin-6 in the brain.

Authors:  Iain L Campbell; Maria Erta; Sue Ling Lim; Ricardo Frausto; Ulrike May; Stefan Rose-John; Jürgen Scheller; Juan Hidalgo
Journal:  J Neurosci       Date:  2014-02-12       Impact factor: 6.167

8.  Hepatocellular hyperplasia, plasmacytoma formation, and extramedullary hematopoiesis in interleukin (IL)-6/soluble IL-6 receptor double-transgenic mice.

Authors:  P Schirmacher; M Peters; G Ciliberto; M Blessing; J Lotz; K H Meyer zum Büschenfelde; S Rose-John
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

9.  IL-6-trans-signalling increases rapid-eye-movement sleep in rats.

Authors:  Ulrike May; Thomas Schiffelholz; Paul Christian Baier; James M Krueger; Stefan Rose-John; Jürgen Scheller
Journal:  Eur J Pharmacol       Date:  2009-04-19       Impact factor: 4.432

10.  Interleukin-6 is both necessary and sufficient to produce perioperative neurocognitive disorder in mice.

Authors:  J Hu; X Feng; M Valdearcos; D Lutrin; Y Uchida; S K Koliwad; M Maze
Journal:  Br J Anaesth       Date:  2018-02-03       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.